MALE BREAST CANCER TREATMENT: CLINICAL CASE

Relevance: Male breast cancer (BC) is one of the rarest diseases and accounts for 1/100 detected BC cases in both sexes. About
 30-70% men develop against background gynecomastia, particularly its nodular form. The biology this
 disease differs men, but approaches to diagnostics treatment are usually extrapolated from those used women.
 This study aimed demonstrate results each stage a male patient with treatment.
 Methods: article presents clinical case diagnosed «Cancer right St III (T4NxM0),
 Edematous-infiltrative form an intraductal component, upper outer localization. Immunohistochemically luminal subtype B
 without Her2neu expression». data literary sources protocols on diagnosis were
 also reviewed.
 Results: received four courses preoperative chemotherapy according “AС” scheme Doxorubicin 60 mg/m2
 (CD 120 mg) + Cyclophosphamide 600 1200 mg). Intermediate instrumental laboratory control assessing the
 response RECIST criteria planned.
 Conclusion: presented rare demonstrates that at initial remain
 same as recommended women. Identical adjuvant regimens applicable. Since most male
 express estrogen receptors, endocrine therapy such tamoxifen kind routine treatment. article
 describes performed patient. second
 part publication will present surgical recommendations issued to